The Oncology Institute, Inc.
TOIHealthcareNASDAQMedical Care Facilities · Last scanned Jun 3, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, The Oncology Institute, Inc. focuses on Medical Care Facilities services and products. The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. The $458.9M market capitalization puts TOI squarely in small-cap range for its industry. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.
Market Cap
$458.9M
Beta
0.36
P/E (TTM)
—
P/E (Fwd)
-28.69
EPS (TTM)
$-0.35
EPS (Fwd)
$-0.16
ROE
—
ROA
-12.3%
Cash
$30.3M
Total Debt
$104.9M
Free CF
-$15.3M
52W Change
43.4%
Annual Financials
Cash vs Debt
On the balance sheet, TOI has $30.3M in cash with $104.9M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company is burning cash, with free cash flow at -$15.3M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Revenue has grown from $252.5M (2022) to $502.7M (2025), reflecting a 99% increase over the period.
TOI's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence The Oncology Institute, Inc.'s trajectory.